# Risk: __Contamination of blood products__ (PBN__Risk_2053)

## Property: has_RiskISO_Impact

* [Biodiversity and ecosystem services](../RiskISO/PBN__RiskISO_Purpose_4)

## Property: has_RiskTechnology

* [pathogen reduction technology](../Technology/PBN__Technology_1535)
* [improved screening and testing methods](../Technology/PBN__Technology_1536)

## Property: has_RiskSubject

* [blood donors](../Stakeholder/PBN__Stakeholder_1378)
* [blood recipients](../Stakeholder/PBN__Stakeholder_1379)

## Property: has_RiskType

* [technological](../RiskType/PBN__RiskType_5)

## Property: has_RiskISO_Purpose

* [Responsible resource use](../RiskISO/PBN__RiskISO_Impact_4)

## Property: has_RiskOwner

* [blood banks](../Stakeholder/PBN__Stakeholder_1380)
* [healthcare providers](../Stakeholder/PBN__Stakeholder_121)

## Property: has_RiskMitigation

* [Research and development of pathogen reduction technologies, improved blood safety practices](../RiskMitigation/PBN__RiskMitigation_2684)

## Property: has_RiskName

Increased risk to public health and blood supply

## Property: has_RiskDescription

Contamination of blood products with known or unknown pathogens

## Property: has_RiskSource

* [semenza_prototype_2015](../Article/PBN__Article_212)

## Property: has_RiskGBN

* [No](../RiskGBN/PBN__RiskGBN_0)

## Property: has_RiskHealth

* [physical](../RiskHealth/PBN__RiskHealth_0)

